HMGB1 and serum lipopolysaccharide activity: FPS-ZM1, a RAGE inhibitor (34–36), was used to further elucidate whether the binding of HMGB1 to RAGE determines the vascular injury function of the HMGB1/RAGE axis in endotoxemia.